Stocks
Chemed Corporation Financial Statements (CHE) |
||||||||||
| Chemed Corporationsmart-lab.ru | % | 2023Q3 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 30.09.2023 | 27.10.2023 | 29.02.2024 | 31.03.2024 | 29.04.2024 | 29.04.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 564.5 | 564.5 | 585.9 | 589.2 | 589.2 | 2 329 | |||
| Operating Income, bln rub | 86.9 | 86.9 | 111.4 | 72.3 | 72.3 | 342.9 | ||||
| EBITDA, bln rub | ? | 109.1 | 109.1 | 126.9 | 88.1 | 88.1 | 412.3 | |||
| Net profit, bln rub | ? | 75.0 | 75.0 | 90.1 | 65.0 | 65.0 | 295.0 | |||
| OCF, bln rub | ? | 28.9 | 28.9 | 108.6 | 84.5 | 222.0 | ||||
| CAPEX, bln rub | ? | 11.7 | 11.7 | 11.8 | 12.2 | 35.6 | ||||
| FCF, bln rub | ? | 17.3 | 17.3 | 96.8 | 72.4 | 186.4 | ||||
| Dividend payout, bln rub | 6.03 | 6.03 | 6.06 | 6.05 | 18.1 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||
| Dividend payout ratio, % | 8.05% | 8.05% | 6.72% | 0.00% | 9.31% | 6.15% | ||||
| OPEX, bln rub | 111.1 | 111.1 | 100.6 | 116.0 | 116.0 | 443.6 | ||||
| Cost of production, bln rub | 362.4 | 362.4 | 373.9 | 400.9 | 400.9 | 1 538 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 0.444 | 0.444 | 0.342 | 0.425 | 0.425 | 1.64 | ||||
| Assets, bln rub | 1 562 | 1 562 | 1 761 | 1 728 | 1 728 | 1 728 | ||||
| Net Assets, bln rub | ? | 1 019 | 1 019 | 1 108 | 1 183 | 1 183 | 1 183 | |||
| Debt, bln rub | 137.0 | 137.0 | 155.1 | 146.1 | 159.7 | 159.7 | ||||
| Cash, bln rub | 173.2 | 173.2 | 264.0 | 313.4 | 313.4 | 313.4 | ||||
| Net debt, bln rub | -36.2 | -36.2 | -108.8 | -167.2 | -153.6 | -153.6 | ||||
| Ordinary share price, rub | 519.7 | 519.7 | 584.8 | 641.9 | 564.5 | |||||
| Number of ordinary shares, mln | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | 15.1 | ||||
| Market cap, bln rub | 7 834 | 7 834 | 8 829 | 0 | 9 707 | 8 536 | ||||
| EV, bln rub | ? | 7 798 | 7 798 | 8 720 | -167 | 9 553 | 8 382 | |||
| Book value, bln rub | 341 | 341 | 433 | 592 | 504 | 504 | ||||
| EPS, rub | ? | 4.97 | 4.97 | 5.96 | 4.30 | 4.30 | 19.5 | |||
| FCF/share, rub | 1.15 | 1.15 | 6.41 | 0.00 | 4.79 | 12.3 | ||||
| BV/share, rub | 22.7 | 22.7 | 28.7 | 39.1 | 33.3 | 33.3 | ||||
| EBITDA margin, % | ? | 19.3% | 19.3% | 21.7% | 15.0% | 15.0% | 17.7% | |||
| Net margin, % | ? | 13.3% | 13.3% | 15.4% | 11.0% | 11.0% | 12.7% | |||
| FCF yield, % | ? | 3.30% | 3.30% | 3.10% | 3.11% | 2.18% | ||||
| ROE, % | ? | 24.0% | 24.0% | 24.6% | 23.9% | 23.9% | 24.9% | |||
| ROA, % | ? | 15.7% | 15.7% | 15.5% | 16.4% | 16.4% | 17.1% | |||
| P/E | ? | 32.0 | 32.0 | 32.4 | 0.00 | 34.3 | 28.9 | |||
| P/FCF | 453.6 | 30.3 | 32.3 | 0.00 | 32.1 | 45.8 | ||||
| P/S | ? | 3.52 | 3.52 | 3.90 | 0.00 | 4.23 | 3.67 | |||
| P/BV | ? | 22.9 | 22.9 | 20.4 | 0.00 | 19.3 | 16.9 | |||
| EV/EBITDA | ? | 20.3 | 20.3 | 21.1 | -0.41 | 23.3 | 20.3 | |||
| Debt/EBITDA | -0.09 | -0.09 | -0.26 | -0.41 | -0.37 | -0.37 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| CAPEX/Revenue, % | 2.06% | 2.06% | 2.01% | 0.00% | 2.06% | 1.53% | ||||
| Chemed Corporation shareholders | ||||||||||
